Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SBC Medical Group Holdings (SBC) EBITDA Margin (2023 - 2025)

SBC Medical Group Holdings (SBC) has disclosed EBITDA Margin for 3 consecutive years, with 13.94% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBITDA Margin fell 3022.0% year-over-year to 13.94%, compared with a TTM value of 20.5% through Sep 2025, down 3711.0%, and an annual FY2024 reading of 14.61%, up 84.0% over the prior year.
  • EBITDA Margin was 13.94% for Q3 2025 at SBC Medical Group Holdings, down from 25.09% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 11491.98% in Q4 2023 and bottomed at 26.27% in Q4 2024.
  • Average EBITDA Margin over 3 years is 1296.0%, with a median of 17.91% recorded in 2024.
  • The sharpest move saw EBITDA Margin plummeted -1151825bps in 2024, then soared 5060bps in 2025.
  • Year by year, EBITDA Margin stood at 11491.98% in 2023, then plummeted by -100bps to 26.27% in 2024, then surged by 153bps to 13.94% in 2025.
  • Business Quant data shows EBITDA Margin for SBC at 13.94% in Q3 2025, 25.09% in Q2 2025, and 66.21% in Q1 2025.